Upgrades
- Sutro Biopharma (STRO) upgraded by Piper Sandler from Neutral to Overweight
- Incyte (INCY) upgraded by Stifel from Hold to Buy
- Jade Biosciences (JBIO) upgraded by Guggenheim from Neutral to Buy
- Celanese (CE) upgraded by Wells Fargo from Equal Weight to Overweight
- Umicore (UMICY) upgraded by Jefferies from Hold to Buy
- Hudson Technologies (HDSN) upgraded by B. Riley from Neutral to Buy
- Wix.com (WIX) upgraded by Wells Fargo from Equal Weight to Overweight
- Smurfit Westrock (SW) upgraded by Jefferies from Hold to Buy
- Celsius Holdings (CELH) upgraded by TD Cowen from Hold to Buy
- Cisco (CSCO) upgraded by Deutsche Bank from Hold to Buy
- Freeport-McMoRan (FCX) upgraded by Scotiabank from Sector Perform to Outperform
Investors Can't Afford to Miss This [sponsor]
To carry out Trump's Executive Order #14196 initiative, the administration will have to partner with a handful of U.S. companies that control the "reserve accounts" sitting on trillions of dollars' worth of untapped natural resources. I've spent months digging into this – and I've identified three companies that have already been granted "emergency status" and fast-track approvals. I believe their shares could skyrocket once new capital starts moving into the sector. See the three stocks that I expect to be the biggest winners as this plan rolls.
To carry out Trump's Executive Order #14196 initiative, the administration will have to partner with a handful of U.S. companies that control the "reserve accounts" sitting on trillions of dollars' worth of untapped natural resources. I've spent months digging into this – and I've identified three companies that have already been granted "emergency status" and fast-track approvals. I believe their shares could skyrocket once new capital starts moving into the sector. See the three stocks that I expect to be the biggest winners as this plan rolls.
Downgrades
- Sarepta (SRPT) downgraded by BMO Capital from Outperform to Market Perform
- Aviva (AIVAF) downgraded by Barclays from Overweight to Equal Weight
- Angi Inc. (ANGI) downgraded by Citizens JMP from Outperform to Market Perform
- Symrise (SYIEY) downgraded by Jefferies from Hold to Underperform
- Arkema (ARKAY) downgraded by Jefferies from Buy to Hold
- Clariant (CLZNY) downgraded by Jefferies from Buy to Hold
- Pros Holdings (PRO) downgraded by Baird from Outperform to Neutral
- Sarepta (SRPT) downgraded by Piper Sandler from Overweight to Neutral
- Packaging Corp. (PKG) downgraded by Jefferies from Buy to Hold
- Porsche AG (DRPRF) downgraded by BofA from Neutral to Underperform
- CoreWeave (CRWV) downgraded by BofA from Buy to Neutral
- Sarepta (SRPT) downgraded by H.C. Wainwright from Neutral to Sell
MAG-7 Stocks Are Dead—Here's What Killed Them [sponsor]
The old way of investing in tech giants is over. A NEW strategy unlocks 146X more income on the SAME underlying stocks (like Meta, Apple, and Amazon) -- WITHOUT options trading. Click here to uncover the NEW MAG-7 alternative.
The old way of investing in tech giants is over. A NEW strategy unlocks 146X more income on the SAME underlying stocks (like Meta, Apple, and Amazon) -- WITHOUT options trading. Click here to uncover the NEW MAG-7 alternative.
Upgrades & Downgrades provided by The Fly at http://www.thefly.com. The Fly is a leading digital publisher of real-time financial news. Our financial market experts understand that news impacting stock prices can originate from anywhere, at any time. The Fly team scours all sources of company news, from mainstream to cutting-edge, then filters out the noise to deliver short-form stories consisting of only market moving content. Become an informed investor. Try all of The Fly’s services FREE for 14 days by clicking here.